-
1
Sequential therapy with darolutamide in patients with non‐metastatic castration‐resistant prostate cancer resistant to enzalutamide or apalutamide
Published 2023-02-01Subjects: Get full text
Article -
2
Nomogram Analysis for Predicting Response to Androgen‐Receptor‐Axis‐Targeted Therapies in Patients With Metastatic Castration‐Resistant Prostate Cancer
Published 2024-11-01Subjects: “…androgen‐receptor‐axis‐targeted therapies (ARAT)…”
Get full text
Article -
3